Add BrightSurf on Google Email

Feed a cold -- starve a tumor

Researchers found that 2-deoxyglucose reduces tumor size in mice on either diet, while a carbohydrate-free diet led to greater tumor growth. This combination imposes energy stress on tumors and correlates with lower serum glucose levels.

SourceBMC (BioMed Central)·JournalCell & Bioscience·DateOct 20, 2011

Brain tumors found to have a 2-tier system

Researchers have classified brain tumors into two distinct subgroups based on genetic analysis, revealing that one subgroup has a favorable prognosis while the other is more aggressive. The study provides valuable insights for better treatment options and could lead to targeted therapies for patients with ependymoma.

SourceHelmholtz Association·JournalCancer Cell·DateAug 23, 2011

Potential new eye tumor treatment discovered

A study published in Genes & Development reveals a specific RNA cluster, miR-17~92, plays a key role in the growth of retinoblastoma, a rare form of childhood eye cancer. The researchers found that overexpression of this microRNA cluster helps cells proliferate despite the loss of tumor-suppressing protein Rb.

SourceCarnegie Institution for Science·JournalGenes & Development·DateAug 4, 2011

Children and adolescent mobile phone users at no greater risk of brain cancer than non-users

A recent study published in the Journal of the National Cancer Institute found that children and adolescent mobile phone users are not at a statistically significant increased risk of brain cancer compared to non-users. The study included data from over 352 brain cancer patients and 646 control subjects, and found no clear exposure-res...

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateJul 27, 2011

New model for studying germ cell tumors in testes enlists embryonic stem cells

Researchers have created a new model to study germ cell tumors in testes by transplanting embryonic stem cells into mouse models. The resulting tumors mimic the early stages of tumor development and offer valuable insights into the genetic regulation of these cancers. This approach has potential applications for developing novel therap...

To combat deadly brain cancer, target the stem cells

Researchers have discovered an enzyme in glioblastoma stem cells that allows them to grow and seed tumors. Unlike normal stem cells, these enzymes are not shared, making them a potential target for therapy. The study found that inhibiting this pathway slows the growth of brain tumors in mice, offering hope for improved treatment options.

SourceCell Press·JournalCell·DateJul 7, 2011

What causes brain cancer?

Researchers have discovered potential regulatory networks in glioblastoma using microRNAs and transcription factors. The study identified 54 feed-forward loops with functions important to carcinogenesis and unique functions specific to each FFL.

SourceInderscience Publishers·JournalInternational Journal of Computational Biology and Drug Design·DateJul 6, 2011

Iron key to brain tumor drug delivery

Scientists at Penn State College of Medicine have created a new approach to treating brain tumors by targeting the ferritin protein with siRNA. By reducing ferritin levels in cancer cells, the sensitivity to chemotherapy can be increased, allowing for lower doses and potentially fewer side effects.

SourcePenn State·JournalCancer Research·DateJun 2, 2011

Call of the riled

Researchers discovered that cancer cells generate a 'stress response' signal that induces nearby macrophages to issue a similar stress response, promoting inflammation and tumor development. This finding presents a potential target for tumor-specific therapies.

SourceUniversity of California - San Diego·JournalProceedings of the National Academy of Sciences·DateApr 4, 2011

Which side of the brain rotates a mental picture?

A multidisciplinary team found that patients with tumors in the right parietal cortex struggled to process categorical spatial information, leading to errors in mental rotation tasks. The left prefrontal cortex was also affected, causing difficulties in setting up specific programs within the brain for task organization.

SourceElsevier·JournalCortex·DateMar 9, 2011

JCI online early table of contents: Feb. 14, 2011

Researchers identify Hunk as a key protein required for HER2/neu-induced mammary tumorigenesis, potentially leading to new treatments for aggressive breast cancer. A new compound, ABT-737, sensitizes human cancer cells to apoptosis in hypoxic regions, offering a potential combination therapy for solid tumors.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 14, 2011

JCI table of contents: Dec. 22, 2010

The study found that overexpression of the Sox3 gene causes frequent XX male sex reversal, while a new regulatory pathway involving the ventral premammillary nucleus is linked to leptin's effect on puberty onset. Additionally, arsenic trioxide may be beneficial for treating certain brain tumors.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateDec 22, 2010

Picking a poison for brain tumors: Arsenic

Researchers found that arsenic trioxide inhibits the growth of medulloblastoma and Ewing sarcoma cell lines by blocking the Hedgehog/GLI1 signaling pathway. The compound improved survival in a mouse model of medulloblastoma, suggesting its potential as a therapeutic option.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateDec 22, 2010

Insight offers new angle of attack on variety of brain tumors

A new research paper published in the Journal of the National Cancer Institute reveals a genetic mutation that leads to abnormal metabolic processes in gliomas, potentially leading to targeted therapies. The study shows that almost all tumors with IDH mutations have the same methylation pattern.

SourceBrown University·JournalJNCI Journal of the National Cancer Institute·DateDec 15, 2010

JCI online early table of contents: Dec. 1, 2010

Researchers identified a crucial protein, LXR-beta, involved in the negative side effects of glucocorticoid drugs. Targeting this protein may lead to safer drug designs. Additionally, TXNL2 is found to protect human breast cancer cells from oxidative stress, while mutations in SLC1A1 cause rare kidney disorder dicarboxylic aminoaciduria.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateDec 1, 2010